Cancer
Genmab reports Rina-S ovarian cancer results with a 45.9% response rate
Endpoints News reported that Genmab’s Rina-S had a 45.9% objective response rate in patients with platinum-resistant ovarian cancer.
Reported by 3 outlets · Tuesday, October 6, 2026
Photo: CC0
The original reports on this story are listed below.
Research
The Nobel recognized work that lets researchers use light to switch nerve cells on or off and study brain circuits.
Reported by 10 outlets
Infectious disease
WHO said the worker’s cause of death has not been confirmed and the risk to the general population appears low.
Reported by 6 outlets
Outbreaks
New York declared an emergency with 108 measles cases and expanded who can administer vaccines, as Pennsylvania reported 1,004 cases.
Reported by 3 outlets